Substance Use

Drug overdose deaths increased approximately 30% between 2019 and 2020, likely driven by fentanyl and COVID-19 pandemic, according to new CDC report.

The FDA today denied Juul Labs' premarket tobacco product applications and ordered all products removed from shelves nationwide, ending a 2-year review.

Approximately one-third of survey respondents with AUD relapsed within 1 year of stopping. Find a profile here of the experience of recovery from those who are trying.

Study addresses the concern that state opioid prescription laws may lead to some chronic pain patients missing out on critical pain treatment.

More than one-third of survey respondents began drinking before age 15; the heaviest drinkers had double the risk for cirrhosis, CVD, pancreatitis, and neuropathy.

A nondescript, postage-paid envelope accompanying an opioid prescription, and patient education on discarding unused tablets are proposed.

Persons with ASCVD who quit smoking could gain 5 more years of life--similar to the outcome of intensive medical treatment while continuing to smoke.

A new study of more than 2 million US adults and adolescents who could benefit from medication for OUD reveals only 1 in 4 reported past-year use.

US adults smoked less cigarettes in 2020 than in 2019, but a diverse landscape of tobacco product use persists, according to latest findings released by the CDC.

In 2020, 19% of US adults used at least 1 tobacco product, a decline from 20.8% in 2019, according to new data released by the CDC.